Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regenxbio

6.67
-0.3800-5.39%
Post-market: 6.50-0.1700-2.55%19:26 EDT
Volume:827.95K
Turnover:5.49M
Market Cap:334.07M
PE:-1.45
High:6.74
Open:6.55
Low:6.45
Close:7.05
Loading ...
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2022

Major Issues Report

8-K - Current report
Mar 18, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 02, 2021

Major Issues Report

8-K - Current report
Nov 02, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K - Current report